Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Bicycle Therapeutics PLC

NASDAQ: BCYC · Life Sciences · 4 alerts · CIK 1761612

Share price
$3.18Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Bicycle Therapeutics PLC filings on SEC EDGAR ↗

7:13 AM ET 10-Q
Financial Results

Bicycle Therapeutics Q3 2026 Results: Net Loss of $10.5M, Loss Narrows

Bicycle Therapeutics reported collaboration revenue of $34.1 million for the quarter ended September 30, 2026, a significant increase from $11.7 million in the prior year. The company reduced its quarterly net loss to $9.3 million compared to $58.9 million in 2025, primarily driven by higher revenue and a decrease in research and development expenses following a strategic reprioritization.

Key figure
Net loss $10.5M
7:06 AM ET 8-K
Financial Results

Bicycle Therapeutics Financial Results

Bicycle Therapeutics reported third quarter 2026 financial results, highlighting a cash position of $469.9 million and a runway extending into 2030. The company also announced that the FDA granted Orphan Drug Designation to nuzefatide pevedotin for pancreatic cancer and plans to initiate its first company-sponsored radioligand clinical trial in 2H 2027.

“We are pleased with the continued progress made across our pipeline during the third quarter, as we advance nuzefatide pevedotin in the Phase 2 clinical trial in patients with recurrent pancreatic ductal adenocarcinoma and build our emerging pipeline of next-generation radioligands.”

Kevin Lee, Ph.D., Bicycle CEO

“We remain focused on disciplined execution across our prioritized programs and believe our growing clinical data continue to demonstrate the potential of Bicycle® molecules to deliver highly targeted therapies with differentiated benefit/risk profiles.”

Kevin Lee, Ph.D., Bicycle CEO

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.